| Disposition of Arakoda®-Branded Tafenoquine Purchased under Contract W81XWH-19-C-0181 |
No Responsive Documents |
U.S. Army Medical Materiel Development Activity |
United States of America |
| Records of Distribution of Hydroxychloroquine and Chloroquine from the Strategic National Stockpile |
Awaiting Response |
Department of Health and Human Services |
United States of America |
| Records of Clinical Experience and Other Unpublished Evidence Cited in CDC COVID-19 Treatment Options Document |
No Responsive Documents |
Centers for Disease Control and Prevention |
United States of America |
| Request for Emergency Use Authorization for Use of Chloroquine or Hydroxychloroquine for Treatment of COVID-19 (Deparment of Health and Human Services) |
Awaiting Response |
Deparment of Health and Human Services |
United States of America |
| Request for Emergency Use Authorization for Use of Chloroquine or Hydroxychloroquine for Treatment of COVID-19 (Food and Drug Administration) |
Rejected |
Food and Drug Administration |
United States of America |